JP2013525355A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525355A5
JP2013525355A5 JP2013506202A JP2013506202A JP2013525355A5 JP 2013525355 A5 JP2013525355 A5 JP 2013525355A5 JP 2013506202 A JP2013506202 A JP 2013506202A JP 2013506202 A JP2013506202 A JP 2013506202A JP 2013525355 A5 JP2013525355 A5 JP 2013525355A5
Authority
JP
Japan
Prior art keywords
formula
compound
optionally substituted
alkyl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013506202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/032822 external-priority patent/WO2011133442A1/en
Publication of JP2013525355A publication Critical patent/JP2013525355A/ja
Publication of JP2013525355A5 publication Critical patent/JP2013525355A5/ja
Pending legal-status Critical Current

Links

JP2013506202A 2010-04-19 2011-04-18 チアゾリジンジオン化合物の新規合成 Pending JP2013525355A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32550210P 2010-04-19 2010-04-19
US61/325,502 2010-04-19
US32749810P 2010-04-23 2010-04-23
US61/327,498 2010-04-23
PCT/US2011/032822 WO2011133442A1 (en) 2010-04-19 2011-04-18 Novel synthesis for thiazolidinedione compounds

Publications (2)

Publication Number Publication Date
JP2013525355A JP2013525355A (ja) 2013-06-20
JP2013525355A5 true JP2013525355A5 (enExample) 2014-04-24

Family

ID=44148625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013506202A Pending JP2013525355A (ja) 2010-04-19 2011-04-18 チアゾリジンジオン化合物の新規合成

Country Status (15)

Country Link
US (1) US8937182B2 (enExample)
EP (1) EP2560956B1 (enExample)
JP (1) JP2013525355A (enExample)
KR (1) KR101781665B1 (enExample)
CN (1) CN102947269B (enExample)
AU (1) AU2011242956B2 (enExample)
CA (1) CA2796437C (enExample)
DK (1) DK2560956T3 (enExample)
ES (1) ES2610623T3 (enExample)
HU (1) HUE030263T2 (enExample)
MX (1) MX2012012092A (enExample)
NZ (1) NZ602883A (enExample)
PL (1) PL2560956T3 (enExample)
RU (1) RU2012148908A (enExample)
WO (1) WO2011133442A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ604423A (en) * 2010-06-24 2015-01-30 Alkermes Pharma Ireland Ltd Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
CA2807662C (en) * 2010-08-10 2019-10-08 Metabolic Solutions Development Company, Llc Synthesis for thiazolidinedione compounds
KR101857307B1 (ko) 2010-08-10 2018-05-11 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 티아졸리딘디온 화합물의 합성법
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
EP3749292A1 (en) 2018-02-08 2020-12-16 ENYO Pharma Use of modulators of neet proteins for the treatment of infection

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
US5143930A (en) 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
KR100249988B1 (ko) * 1991-04-11 2000-04-01 로렌스 티. 마이젠헬더 티아졸리딘디온 유도체, 그의 제조방법 및 용도
NO302471B1 (no) 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
JPH07188227A (ja) * 1993-12-24 1995-07-25 Japan Tobacco Inc チアゾリジン誘導体及びオキサゾール誘導体
SE9702305D0 (sv) 1997-06-17 1997-06-17 Astra Ab New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
AP869A (en) 1998-01-05 2000-09-04 Pfizer 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents.
US7407978B2 (en) 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
FR2817144B1 (fr) 2000-11-29 2003-01-03 Micro Mega Sa Sequence d'instruments canalaires pour l'execution d'un protocole operatoire d'endodontie
WO2003029251A1 (en) * 2001-09-28 2003-04-10 Biocon Limited Novel process for the synthesis of thiazolidinedione derivatives
FR2861069B1 (fr) 2003-10-17 2005-12-09 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
EP2902026B1 (en) 2006-03-16 2017-10-04 Metabolic Solutions Development Company LLC Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
CN101454006B (zh) 2006-03-16 2012-12-26 新陈代谢解决方案开发公司 用于治疗高血压以及用于降低血脂的噻唑烷二酮类似物
CA2646170A1 (en) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Combination therapies of thiazolidinedione analogues and glucocorticoid agonists
JP5405120B2 (ja) * 2006-12-01 2014-02-05 Msd株式会社 新規フェニル−イソキサゾール−3−オール誘導体
WO2008118327A1 (en) * 2007-03-23 2008-10-02 University Of Toledo Conformationally restrained epothilone analogues as anti-leukemic agents
CN101848901B (zh) 2007-09-14 2012-11-21 新陈代谢解决方案开发公司 用于治疗高血压的噻唑烷二酮类似物
WO2009148195A1 (en) * 2008-06-02 2009-12-10 Daebong Ls, Ltd. 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same
CN103153972A (zh) 2010-04-19 2013-06-12 新陈代谢解决方案开发公司 噻唑烷二酮化合物的新的合成方法
CA2807662C (en) 2010-08-10 2019-10-08 Metabolic Solutions Development Company, Llc Synthesis for thiazolidinedione compounds
KR101857307B1 (ko) 2010-08-10 2018-05-11 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 티아졸리딘디온 화합물의 합성법

Similar Documents

Publication Publication Date Title
US10442825B2 (en) Method of hydrosilylation implementing an organic catalyst derived from germylene
CA2796872A1 (en) Novel synthesis for thiazolidinedione compounds
JP2010510976A5 (enExample)
JP2012526842A5 (enExample)
JP2009523146A5 (enExample)
JP2014529335A5 (enExample)
RU2012148908A (ru) Новый синтез соединений тиазолидиндиона
Karakus et al. Synthesis, crystal structure and ab initio/DFT calculations of a derivative of dithiophosphonates
JP6797268B2 (ja) 新規なヒドロキシフェニルボロン酸エステルとその製造方法、およびヒドロキシビフェニル化合物の製造法
JP2015514729A5 (enExample)
JP6703287B2 (ja) シリルアセタール、オリゴシロキサン、及びそれらの製造方法
JP2010531855A5 (enExample)
US9862812B2 (en) Composition containing nitrogen-containing organoxysilane compound and method for making the same
KR101249361B1 (ko) 고순도 트리스(트리알킬실릴)포스파이트의 제조 방법
JP2013525473A5 (enExample)
JP2014009330A5 (enExample)
MY160912A (en) Formulations
JP2012530113A5 (enExample)
Singh et al. Schiff bases of N-(2-aminoethyl)-3-aminopropyltrimethoxysilane and its silatranes: Synthesis and characterization
JP2012006844A (ja) アルコキシヒドロシランの製造方法
WO2021085535A1 (ja) 化合物及びその製造方法
Gholivand et al. Phosphoramides bearing isoxazole derivative: spectroscopic and structural characterization, study of hydrogen-bonding interactions and two lanthanide complexes (LnIII= Ce and Eu)
JP2011256120A (ja) オルガノアミノシラン化合物の製造方法
JP2012031413A5 (enExample)
JP2008515883A5 (enExample)